Issue 83, 2015

Site-selective multi-porphyrin attachment enables the formation of a next-generation antibody-based photodynamic therapeutic

Abstract

Herein we present a significant step towards next-generation antibody-based photodynamic therapeutics. Site-selective modification of a clinically relevant monoclonal antibody, with a serum-stable linker bearing a strained alkyne, allows for the controlled Cu-free “click” assembly of an in vitro active antibody-based PDT agent using a water soluble azide porpyhrin.

Graphical abstract: Site-selective multi-porphyrin attachment enables the formation of a next-generation antibody-based photodynamic therapeutic

Supplementary files

Article information

Article type
Communication
Submitted
19 Aug 2015
Accepted
24 Aug 2015
First published
24 Aug 2015

Chem. Commun., 2015,51, 15304-15307

Site-selective multi-porphyrin attachment enables the formation of a next-generation antibody-based photodynamic therapeutic

A. Maruani, H. Savoie, F. Bryden, S. Caddick, R. Boyle and V. Chudasama, Chem. Commun., 2015, 51, 15304 DOI: 10.1039/C5CC06985H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements